Virologic Response Following a Switch to Dolutegravir-Based Regimen in People Living With HIV AIDS at a Tertiary Care Center in Nepal. Kathmandu Univ. Med. J. 2022, 20 (4), 438-442. https://doi.org/10.3126/kumj.v20i4.54081.